↓ Skip to main content

PLOS

Phase I Randomized Safety Study of Twice Daily Dosing of Acidform Vaginal Gel: Candidate Antimicrobial Contraceptive

Overview of attention for article published in PLOS ONE, October 2012
Altmetric Badge

Mentioned by

twitter
6 X users
patent
3 patents
facebook
1 Facebook page

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
78 Mendeley
Title
Phase I Randomized Safety Study of Twice Daily Dosing of Acidform Vaginal Gel: Candidate Antimicrobial Contraceptive
Published in
PLOS ONE, October 2012
DOI 10.1371/journal.pone.0046901
Pubmed ID
Authors

Marla J. Keller, Colleen A. Carpenter, Yungtai Lo, Mark H. Einstein, Congzhou Liu, David N. Fredricks, Betsy C. Herold

Abstract

Acidform gel, an acid-buffering product that inactivates spermatozoa, may be an effective topical non-hormonal contraceptive. This study was designed to evaluate the safety of vaginal dosing and effects of Acidform on mucosal immune mediators, antimicrobial properties of genital secretions, and vaginal microbiota.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Unknown 77 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 14%
Student > Bachelor 11 14%
Researcher 9 12%
Student > Ph. D. Student 8 10%
Other 6 8%
Other 9 12%
Unknown 24 31%
Readers by discipline Count As %
Medicine and Dentistry 14 18%
Agricultural and Biological Sciences 7 9%
Nursing and Health Professions 5 6%
Biochemistry, Genetics and Molecular Biology 5 6%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Other 15 19%
Unknown 27 35%